Dr. Azar, you're a specialist in rapid opioid agonist treatment protocols, which avoid a so-called “safe supply” approach in favour of methods that look for medical recovery and abstinence-based pathways. We have that in our treatment centre in Discovery House in Penticton, which is having good results.
Are agonist-based research and treatment methods currently being sufficiently funded by provincial and federal governments?
